Atalanta Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Atalanta Therapeutics is a biotechnology company focused on developing treatments for intractable central nervous system diseases through RNA interference. The company’s core platform uses divalent small interfering RNA (di-siRNA) to achieve durable, selective gene silencing across the brain and spinal cord. It is based in Boston, Massachusetts, and was founded by Anastasia Khvorova, Craig Mello, and Neil Aronin from the RNA Therapeutics Institute at the University of Massachusetts Medical School.

Its portfolio includes a wholly owned pipeline targeting Huntington's disease, genetic epilepsy, severe chronic pain, and other neurological conditions, in addition to programs advanced through a collaboration with Genentech. In June 2025, Joanne Kotz was appointed chief executive officer, succeeding Alicia Secor as part of a planned leadership transition.

Find Atalanta Therapeutics employees' phone numbers or email addresses

Atalanta Therapeutics Global Highlights

Location
Employees

North America
55

Minus sign iconPlus sign icon
  • United States Of America
    55

Asia
1

Minus sign iconPlus sign icon
  • Turkey
    1

Europe
1

Minus sign iconPlus sign icon
  • Netherlands
    1

Atalanta Therapeutics's Leadership

  • Stylized image of a person
    A. S.
    Senior Vice President, Business Development
    Phone icon
  • Stylized image of a person
    A. N.
    Senior Director Information Technology
    Phone icon

Atalanta Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Biotechnology
  • Human Resources
  • Operations
  • Program & Project Management
  • Other
  • Analytics
  • Information Technology
  • Engineering
  • Business
  • Accounting
  • Business Development
  • Community & Social Services
  • Consultant

Contact profiles from Atalanta Therapeutics

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    A. S.
    Senior Vice President, Business Development
    Phone icon
    Jul 01, 2026
  • Stylized image of a person
    A. N.
    Senior Director Information Technology
    Phone icon
    Jan 15, 2025

Frequently Asked Questions

What is Atalanta Therapeutics known for?

Minus sign iconPlus sign icon
Atalanta Therapeutics operates in the Biotechnology Research industry. Explore Atalanta Therapeutics's company overview page for more information.

What is Atalanta Therapeutics's most common email format?

Minus sign iconPlus sign icon
Atalanta Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Atalanta Therapeutics email formats with LeadIQ.

How many employees does Atalanta Therapeutics have currently?

Minus sign iconPlus sign icon
Atalanta Therapeutics has approximately 42 employees as of July 2026. These team members are located across 3 continents, including North AmericaAsiaEurope.

Who are Atalanta Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Atalanta Therapeutics's key employees include:

  • Senior Vice President, Business Development: A. S.
  • Senior Director Information Technology: A. N.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.